Crystallographic analysis of RNA-ligand complexes. Towards rational design oflead compounds for development of therapies against neurodegenerative disorders
2022/45/B/NZ7/03543
Keywords
Descriptors
- NZ7_014: Farmacja, farmakoterapia, farmakologia
- NZ1_004: Biologia strukturalna
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Instytut Chemii Bioorganicznej PAN
Voivodeship: wielkopolskie
Principal investigator (from the host institution)
dr hab. Agnieszka Ludmiła Kiliszek
Number of co-investigators in the project: 4
Call
OPUS 23 – announced on 2022-03-28
- Amount awarded
- 2 045 208 PLN
- Project start date
- 2023-01-20
- Project end date
- 2028-01-19
- Project duration
- 60 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Antisense RNA C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms a triplex-like structure and binds small synthetic ligand
- Authors:
- Leszek Błaszczyk, Marcin Ryczek, Bimolendu Das, Martyna Mateja-Pluta, Magdalena Bejger, Joanna Śliwiak, Kazuhiko Nakatani, Agnieszka Kiliszek
- Academic press:
- Nucleic Acids Research (year: 2024, volume: 52, pages: 6707-6717), Publisher: Oxford Academic
- Status:
- Published
- DOI:
- 10.1093/nar/gkae376 – link to the publication